Work

Computational pathology to predict docetaxel benefit in patients with metastatic hormone-sensitive prostate cancer from the CHAARTED trial (ECOG-ACRIN E3805).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.1560

Authors: Sebastian R. Medina, Naoto Tokuyama, Kamal Hammouda, Tilak Pathak, Tuomas Mirtti, Pingfu Fu, Shilpa Gupta, Priti Lal, Christopher Sweeney, Anant Madabhushi

Institutions: The Wallace H. Coulter Department of Biomedical Engineering, Emory University, Helsinki University Hospital, Case Western Reserve University, Cleveland Clinic, University of Pennsylvania, The University of Adelaide

Language: English

Topic: AI in cancer detection

Subfield: Artificial Intelligence

Field: Computer Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Veterans Affairs, National Heart, Lung, and Blood Institute, National Institute of Biomedical Imaging and Bioengineering, DOD Peer Reviewed Cancer Research Program

Awards: G2689512122, G2702511943, G3075835325, G8010369515

OpenAlex ID: W4410808332

Cites:

Cited by: 1

Related to: 10